Aristeia Capital’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,200,000
Closed -$11.9M 649
2021
Q3
$11.9M Hold
1,200,000
0.22% 123
2021
Q2
$11.9M Buy
+1,200,000
New +$11.9M 0.24% 127